nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—AOX1—Raloxifene—breast cancer	0.147	0.266	CbGbCtD
Zaleplon—CYP3A4—breast cancer	0.132	1	CbGaD
Zaleplon—AOX1—Methotrexate—breast cancer	0.0394	0.0713	CbGbCtD
Zaleplon—CYP3A5—Lapatinib—breast cancer	0.0293	0.053	CbGbCtD
Zaleplon—CYP3A4—Exemestane—breast cancer	0.0226	0.0409	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Tamoxifen—breast cancer	0.0195	0.0354	CbGbCtD
Zaleplon—CYP3A7—Tamoxifen—breast cancer	0.0195	0.0354	CbGbCtD
Zaleplon—CYP3A4—Letrozole—breast cancer	0.0192	0.0347	CbGbCtD
Zaleplon—CYP3A4—Anastrozole—breast cancer	0.0171	0.031	CbGbCtD
Zaleplon—CYP3A4—Toremifene—breast cancer	0.0156	0.0283	CbGbCtD
Zaleplon—CYP3A7—Paclitaxel—breast cancer	0.0152	0.0275	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Paclitaxel—breast cancer	0.0152	0.0275	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Irinotecan—breast cancer	0.015	0.0272	CbGbCtD
Zaleplon—CYP3A7—Irinotecan—breast cancer	0.015	0.0272	CbGbCtD
Zaleplon—CYP3A5—Tamoxifen—breast cancer	0.0146	0.0265	CbGbCtD
Zaleplon—CYP3A4—Fulvestrant—breast cancer	0.0145	0.0263	CbGbCtD
Zaleplon—CYP3A4—Thiotepa—breast cancer	0.013	0.0235	CbGbCtD
Zaleplon—CYP3A4—Ixabepilone—breast cancer	0.0119	0.0215	CbGbCtD
Zaleplon—CYP3A4—Lapatinib—breast cancer	0.0114	0.0207	CbGbCtD
Zaleplon—CYP3A5—Paclitaxel—breast cancer	0.0114	0.0207	CbGbCtD
Zaleplon—CYP3A5—Irinotecan—breast cancer	0.0112	0.0204	CbGbCtD
Zaleplon—CYP3A7—Docetaxel—breast cancer	0.011	0.0199	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Docetaxel—breast cancer	0.011	0.0199	CbGbCtD
Zaleplon—CYP3A4—Raloxifene—breast cancer	0.00865	0.0157	CbGbCtD
Zaleplon—CYP3A5—Docetaxel—breast cancer	0.00824	0.0149	CbGbCtD
Zaleplon—CYP3A4—Vinorelbine—breast cancer	0.00633	0.0115	CbGbCtD
Zaleplon—CYP3A4—Tamoxifen—breast cancer	0.00571	0.0103	CbGbCtD
Zaleplon—CYP3A4—Mitoxantrone—breast cancer	0.00557	0.0101	CbGbCtD
Zaleplon—CYP3A4—Paclitaxel—breast cancer	0.00445	0.00805	CbGbCtD
Zaleplon—CYP3A4—Irinotecan—breast cancer	0.00439	0.00795	CbGbCtD
Zaleplon—CYP3A4—Vinblastine—breast cancer	0.0039	0.00706	CbGbCtD
Zaleplon—CYP3A4—Docetaxel—breast cancer	0.00321	0.00582	CbGbCtD
Zaleplon—CYP3A4—Doxorubicin—breast cancer	0.0024	0.00434	CbGbCtD
Zaleplon—AOX1—nipple—breast cancer	0.000852	0.0591	CbGeAlD
Zaleplon—TSPO—nipple—breast cancer	0.000728	0.0505	CbGeAlD
Zaleplon—TSPO—embryo—breast cancer	0.000601	0.0416	CbGeAlD
Zaleplon—CYP3A7—endocrine gland—breast cancer	0.000542	0.0376	CbGeAlD
Zaleplon—AOX1—endometrium—breast cancer	0.000515	0.0357	CbGeAlD
Zaleplon—TSPO—epithelium—breast cancer	0.00049	0.034	CbGeAlD
Zaleplon—AOX1—uterus—breast cancer	0.000474	0.0329	CbGeAlD
Zaleplon—GABRG2—pituitary gland—breast cancer	0.00047	0.0326	CbGeAlD
Zaleplon—TSPO—skin of body—breast cancer	0.000466	0.0323	CbGeAlD
Zaleplon—AOX1—pituitary gland—breast cancer	0.000466	0.0323	CbGeAlD
Zaleplon—AOX1—adipose tissue—breast cancer	0.000464	0.0321	CbGeAlD
Zaleplon—TSPO—endometrium—breast cancer	0.00044	0.0305	CbGeAlD
Zaleplon—GABRA2—adipose tissue—breast cancer	0.000428	0.0297	CbGeAlD
Zaleplon—AOX1—female reproductive system—breast cancer	0.000426	0.0295	CbGeAlD
Zaleplon—AOX1—adrenal gland—breast cancer	0.000416	0.0288	CbGeAlD
Zaleplon—TSPO—uterus—breast cancer	0.000405	0.0281	CbGeAlD
Zaleplon—TSPO—pituitary gland—breast cancer	0.000398	0.0276	CbGeAlD
Zaleplon—TSPO—adipose tissue—breast cancer	0.000396	0.0275	CbGeAlD
Zaleplon—AOX1—female gonad—breast cancer	0.000388	0.0269	CbGeAlD
Zaleplon—GABRA2—adrenal gland—breast cancer	0.000384	0.0266	CbGeAlD
Zaleplon—TSPO—female reproductive system—breast cancer	0.000364	0.0252	CbGeAlD
Zaleplon—GABRB3—pituitary gland—breast cancer	0.000361	0.025	CbGeAlD
Zaleplon—AOX1—endocrine gland—breast cancer	0.000361	0.025	CbGeAlD
Zaleplon—TSPO—adrenal gland—breast cancer	0.000355	0.0246	CbGeAlD
Zaleplon—TSPO—bone marrow—breast cancer	0.000344	0.0238	CbGeAlD
Zaleplon—TSPO—female gonad—breast cancer	0.000331	0.023	CbGeAlD
Zaleplon—GABRB3—female reproductive system—breast cancer	0.000331	0.0229	CbGeAlD
Zaleplon—TSPO—endocrine gland—breast cancer	0.000308	0.0214	CbGeAlD
Zaleplon—GABRB3—endocrine gland—breast cancer	0.00028	0.0194	CbGeAlD
Zaleplon—AOX1—lymph node—breast cancer	0.000249	0.0173	CbGeAlD
Zaleplon—CYP3A5—adipose tissue—breast cancer	0.000245	0.017	CbGeAlD
Zaleplon—GABRA2—lymph node—breast cancer	0.00023	0.0159	CbGeAlD
Zaleplon—TSPO—lymph node—breast cancer	0.000213	0.0148	CbGeAlD
Zaleplon—CYP3A5—female gonad—breast cancer	0.000205	0.0142	CbGeAlD
Zaleplon—CYP3A5—endocrine gland—breast cancer	0.000191	0.0132	CbGeAlD
Zaleplon—CYP3A4—female reproductive system—breast cancer	0.000169	0.0117	CbGeAlD
Zaleplon—CYP3A4—endocrine gland—breast cancer	0.000143	0.00993	CbGeAlD
Zaleplon—Tinnitus—Methotrexate—breast cancer	3.86e-05	0.000157	CcSEcCtD
Zaleplon—Tachycardia—Capecitabine—breast cancer	3.85e-05	0.000156	CcSEcCtD
Zaleplon—Hypoaesthesia—Epirubicin—breast cancer	3.85e-05	0.000156	CcSEcCtD
Zaleplon—Skin disorder—Capecitabine—breast cancer	3.83e-05	0.000156	CcSEcCtD
Zaleplon—Sweating—Doxorubicin—breast cancer	3.82e-05	0.000155	CcSEcCtD
Zaleplon—Urticaria—Paclitaxel—breast cancer	3.82e-05	0.000155	CcSEcCtD
Zaleplon—Hyperhidrosis—Capecitabine—breast cancer	3.81e-05	0.000155	CcSEcCtD
Zaleplon—Oedema peripheral—Epirubicin—breast cancer	3.81e-05	0.000155	CcSEcCtD
Zaleplon—Hypotension—Docetaxel—breast cancer	3.81e-05	0.000155	CcSEcCtD
Zaleplon—Haematuria—Doxorubicin—breast cancer	3.8e-05	0.000154	CcSEcCtD
Zaleplon—Abdominal pain—Paclitaxel—breast cancer	3.8e-05	0.000154	CcSEcCtD
Zaleplon—Body temperature increased—Paclitaxel—breast cancer	3.8e-05	0.000154	CcSEcCtD
Zaleplon—Hepatobiliary disease—Doxorubicin—breast cancer	3.77e-05	0.000153	CcSEcCtD
Zaleplon—Epistaxis—Doxorubicin—breast cancer	3.76e-05	0.000153	CcSEcCtD
Zaleplon—Anorexia—Capecitabine—breast cancer	3.76e-05	0.000153	CcSEcCtD
Zaleplon—Immune system disorder—Methotrexate—breast cancer	3.73e-05	0.000152	CcSEcCtD
Zaleplon—Dizziness—Fluorouracil—breast cancer	3.73e-05	0.000152	CcSEcCtD
Zaleplon—Visual impairment—Epirubicin—breast cancer	3.73e-05	0.000151	CcSEcCtD
Zaleplon—Rash—Mitoxantrone—breast cancer	3.72e-05	0.000151	CcSEcCtD
Zaleplon—Rash—Irinotecan—breast cancer	3.72e-05	0.000151	CcSEcCtD
Zaleplon—Dermatitis—Irinotecan—breast cancer	3.71e-05	0.000151	CcSEcCtD
Zaleplon—Dermatitis—Mitoxantrone—breast cancer	3.71e-05	0.000151	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Docetaxel—breast cancer	3.71e-05	0.000151	CcSEcCtD
Zaleplon—Chills—Methotrexate—breast cancer	3.71e-05	0.000151	CcSEcCtD
Zaleplon—Headache—Irinotecan—breast cancer	3.69e-05	0.00015	CcSEcCtD
Zaleplon—Headache—Mitoxantrone—breast cancer	3.69e-05	0.00015	CcSEcCtD
Zaleplon—Hypotension—Capecitabine—breast cancer	3.69e-05	0.00015	CcSEcCtD
Zaleplon—Insomnia—Docetaxel—breast cancer	3.69e-05	0.00015	CcSEcCtD
Zaleplon—Paraesthesia—Docetaxel—breast cancer	3.66e-05	0.000149	CcSEcCtD
Zaleplon—Alopecia—Methotrexate—breast cancer	3.65e-05	0.000148	CcSEcCtD
Zaleplon—Dyspnoea—Docetaxel—breast cancer	3.63e-05	0.000148	CcSEcCtD
Zaleplon—Somnolence—Docetaxel—breast cancer	3.62e-05	0.000147	CcSEcCtD
Zaleplon—Mental disorder—Methotrexate—breast cancer	3.62e-05	0.000147	CcSEcCtD
Zaleplon—Rash—Gemcitabine—breast cancer	3.62e-05	0.000147	CcSEcCtD
Zaleplon—Dermatitis—Gemcitabine—breast cancer	3.62e-05	0.000147	CcSEcCtD
Zaleplon—Eye disorder—Epirubicin—breast cancer	3.62e-05	0.000147	CcSEcCtD
Zaleplon—Tinnitus—Epirubicin—breast cancer	3.61e-05	0.000147	CcSEcCtD
Zaleplon—Malnutrition—Methotrexate—breast cancer	3.6e-05	0.000146	CcSEcCtD
Zaleplon—Headache—Gemcitabine—breast cancer	3.6e-05	0.000146	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Capecitabine—breast cancer	3.6e-05	0.000146	CcSEcCtD
Zaleplon—Dyspepsia—Docetaxel—breast cancer	3.59e-05	0.000146	CcSEcCtD
Zaleplon—Insomnia—Capecitabine—breast cancer	3.57e-05	0.000145	CcSEcCtD
Zaleplon—Hypoaesthesia—Doxorubicin—breast cancer	3.56e-05	0.000145	CcSEcCtD
Zaleplon—Rash—Fluorouracil—breast cancer	3.56e-05	0.000145	CcSEcCtD
Zaleplon—Dermatitis—Fluorouracil—breast cancer	3.56e-05	0.000144	CcSEcCtD
Zaleplon—Paraesthesia—Capecitabine—breast cancer	3.54e-05	0.000144	CcSEcCtD
Zaleplon—Decreased appetite—Docetaxel—breast cancer	3.54e-05	0.000144	CcSEcCtD
Zaleplon—Headache—Fluorouracil—breast cancer	3.54e-05	0.000144	CcSEcCtD
Zaleplon—Oedema peripheral—Doxorubicin—breast cancer	3.53e-05	0.000143	CcSEcCtD
Zaleplon—Dysgeusia—Methotrexate—breast cancer	3.52e-05	0.000143	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Docetaxel—breast cancer	3.52e-05	0.000143	CcSEcCtD
Zaleplon—Dyspnoea—Capecitabine—breast cancer	3.52e-05	0.000143	CcSEcCtD
Zaleplon—Nausea—Mitoxantrone—breast cancer	3.5e-05	0.000142	CcSEcCtD
Zaleplon—Nausea—Irinotecan—breast cancer	3.5e-05	0.000142	CcSEcCtD
Zaleplon—Immune system disorder—Epirubicin—breast cancer	3.49e-05	0.000142	CcSEcCtD
Zaleplon—Pain—Docetaxel—breast cancer	3.49e-05	0.000142	CcSEcCtD
Zaleplon—Constipation—Docetaxel—breast cancer	3.49e-05	0.000142	CcSEcCtD
Zaleplon—Back pain—Methotrexate—breast cancer	3.48e-05	0.000141	CcSEcCtD
Zaleplon—Dyspepsia—Capecitabine—breast cancer	3.47e-05	0.000141	CcSEcCtD
Zaleplon—Chills—Epirubicin—breast cancer	3.47e-05	0.000141	CcSEcCtD
Zaleplon—Visual impairment—Doxorubicin—breast cancer	3.45e-05	0.00014	CcSEcCtD
Zaleplon—Asthenia—Paclitaxel—breast cancer	3.45e-05	0.00014	CcSEcCtD
Zaleplon—Decreased appetite—Capecitabine—breast cancer	3.43e-05	0.000139	CcSEcCtD
Zaleplon—Alopecia—Epirubicin—breast cancer	3.42e-05	0.000139	CcSEcCtD
Zaleplon—Nausea—Gemcitabine—breast cancer	3.41e-05	0.000139	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Capecitabine—breast cancer	3.41e-05	0.000138	CcSEcCtD
Zaleplon—Pruritus—Paclitaxel—breast cancer	3.4e-05	0.000138	CcSEcCtD
Zaleplon—Mental disorder—Epirubicin—breast cancer	3.39e-05	0.000138	CcSEcCtD
Zaleplon—Pain—Capecitabine—breast cancer	3.37e-05	0.000137	CcSEcCtD
Zaleplon—Constipation—Capecitabine—breast cancer	3.37e-05	0.000137	CcSEcCtD
Zaleplon—Malnutrition—Epirubicin—breast cancer	3.37e-05	0.000137	CcSEcCtD
Zaleplon—Feeling abnormal—Docetaxel—breast cancer	3.36e-05	0.000136	CcSEcCtD
Zaleplon—Nausea—Fluorouracil—breast cancer	3.35e-05	0.000136	CcSEcCtD
Zaleplon—Eye disorder—Doxorubicin—breast cancer	3.35e-05	0.000136	CcSEcCtD
Zaleplon—Ill-defined disorder—Methotrexate—breast cancer	3.34e-05	0.000136	CcSEcCtD
Zaleplon—Tinnitus—Doxorubicin—breast cancer	3.34e-05	0.000136	CcSEcCtD
Zaleplon—Gastrointestinal pain—Docetaxel—breast cancer	3.33e-05	0.000135	CcSEcCtD
Zaleplon—Anaemia—Methotrexate—breast cancer	3.33e-05	0.000135	CcSEcCtD
Zaleplon—Flatulence—Epirubicin—breast cancer	3.32e-05	0.000135	CcSEcCtD
Zaleplon—Tension—Epirubicin—breast cancer	3.31e-05	0.000134	CcSEcCtD
Zaleplon—Dysgeusia—Epirubicin—breast cancer	3.3e-05	0.000134	CcSEcCtD
Zaleplon—Nervousness—Epirubicin—breast cancer	3.27e-05	0.000133	CcSEcCtD
Zaleplon—Back pain—Epirubicin—breast cancer	3.26e-05	0.000132	CcSEcCtD
Zaleplon—Feeling abnormal—Capecitabine—breast cancer	3.25e-05	0.000132	CcSEcCtD
Zaleplon—Malaise—Methotrexate—breast cancer	3.25e-05	0.000132	CcSEcCtD
Zaleplon—Immune system disorder—Doxorubicin—breast cancer	3.23e-05	0.000131	CcSEcCtD
Zaleplon—Vertigo—Methotrexate—breast cancer	3.23e-05	0.000131	CcSEcCtD
Zaleplon—Gastrointestinal pain—Capecitabine—breast cancer	3.23e-05	0.000131	CcSEcCtD
Zaleplon—Abdominal pain—Docetaxel—breast cancer	3.22e-05	0.000131	CcSEcCtD
Zaleplon—Body temperature increased—Docetaxel—breast cancer	3.22e-05	0.000131	CcSEcCtD
Zaleplon—Chills—Doxorubicin—breast cancer	3.21e-05	0.00013	CcSEcCtD
Zaleplon—Dizziness—Paclitaxel—breast cancer	3.18e-05	0.000129	CcSEcCtD
Zaleplon—Alopecia—Doxorubicin—breast cancer	3.16e-05	0.000129	CcSEcCtD
Zaleplon—Mental disorder—Doxorubicin—breast cancer	3.14e-05	0.000127	CcSEcCtD
Zaleplon—Urticaria—Capecitabine—breast cancer	3.13e-05	0.000127	CcSEcCtD
Zaleplon—Ill-defined disorder—Epirubicin—breast cancer	3.13e-05	0.000127	CcSEcCtD
Zaleplon—Body temperature increased—Capecitabine—breast cancer	3.12e-05	0.000127	CcSEcCtD
Zaleplon—Abdominal pain—Capecitabine—breast cancer	3.12e-05	0.000127	CcSEcCtD
Zaleplon—Malnutrition—Doxorubicin—breast cancer	3.12e-05	0.000127	CcSEcCtD
Zaleplon—Anaemia—Epirubicin—breast cancer	3.11e-05	0.000126	CcSEcCtD
Zaleplon—Agitation—Epirubicin—breast cancer	3.1e-05	0.000126	CcSEcCtD
Zaleplon—Flatulence—Doxorubicin—breast cancer	3.07e-05	0.000125	CcSEcCtD
Zaleplon—Arthralgia—Methotrexate—breast cancer	3.06e-05	0.000124	CcSEcCtD
Zaleplon—Myalgia—Methotrexate—breast cancer	3.06e-05	0.000124	CcSEcCtD
Zaleplon—Chest pain—Methotrexate—breast cancer	3.06e-05	0.000124	CcSEcCtD
Zaleplon—Tension—Doxorubicin—breast cancer	3.06e-05	0.000124	CcSEcCtD
Zaleplon—Dysgeusia—Doxorubicin—breast cancer	3.05e-05	0.000124	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	3.04e-05	0.000124	CcSEcCtD
Zaleplon—Malaise—Epirubicin—breast cancer	3.04e-05	0.000123	CcSEcCtD
Zaleplon—Rash—Paclitaxel—breast cancer	3.03e-05	0.000123	CcSEcCtD
Zaleplon—Dermatitis—Paclitaxel—breast cancer	3.03e-05	0.000123	CcSEcCtD
Zaleplon—Discomfort—Methotrexate—breast cancer	3.03e-05	0.000123	CcSEcCtD
Zaleplon—Nervousness—Doxorubicin—breast cancer	3.03e-05	0.000123	CcSEcCtD
Zaleplon—Vertigo—Epirubicin—breast cancer	3.03e-05	0.000123	CcSEcCtD
Zaleplon—Syncope—Epirubicin—breast cancer	3.02e-05	0.000123	CcSEcCtD
Zaleplon—Back pain—Doxorubicin—breast cancer	3.01e-05	0.000122	CcSEcCtD
Zaleplon—Headache—Paclitaxel—breast cancer	3.01e-05	0.000122	CcSEcCtD
Zaleplon—Palpitations—Epirubicin—breast cancer	2.98e-05	0.000121	CcSEcCtD
Zaleplon—Confusional state—Methotrexate—breast cancer	2.96e-05	0.00012	CcSEcCtD
Zaleplon—Loss of consciousness—Epirubicin—breast cancer	2.96e-05	0.00012	CcSEcCtD
Zaleplon—Anaphylactic shock—Methotrexate—breast cancer	2.94e-05	0.000119	CcSEcCtD
Zaleplon—Asthenia—Docetaxel—breast cancer	2.92e-05	0.000119	CcSEcCtD
Zaleplon—Hypertension—Epirubicin—breast cancer	2.91e-05	0.000118	CcSEcCtD
Zaleplon—Ill-defined disorder—Doxorubicin—breast cancer	2.89e-05	0.000117	CcSEcCtD
Zaleplon—Pruritus—Docetaxel—breast cancer	2.88e-05	0.000117	CcSEcCtD
Zaleplon—Nervous system disorder—Methotrexate—breast cancer	2.88e-05	0.000117	CcSEcCtD
Zaleplon—Anaemia—Doxorubicin—breast cancer	2.88e-05	0.000117	CcSEcCtD
Zaleplon—Chest pain—Epirubicin—breast cancer	2.87e-05	0.000116	CcSEcCtD
Zaleplon—Arthralgia—Epirubicin—breast cancer	2.87e-05	0.000116	CcSEcCtD
Zaleplon—Myalgia—Epirubicin—breast cancer	2.87e-05	0.000116	CcSEcCtD
Zaleplon—Agitation—Doxorubicin—breast cancer	2.86e-05	0.000116	CcSEcCtD
Zaleplon—Anxiety—Epirubicin—breast cancer	2.86e-05	0.000116	CcSEcCtD
Zaleplon—Nausea—Paclitaxel—breast cancer	2.86e-05	0.000116	CcSEcCtD
Zaleplon—Skin disorder—Methotrexate—breast cancer	2.85e-05	0.000116	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.85e-05	0.000116	CcSEcCtD
Zaleplon—Hyperhidrosis—Methotrexate—breast cancer	2.84e-05	0.000115	CcSEcCtD
Zaleplon—Discomfort—Epirubicin—breast cancer	2.83e-05	0.000115	CcSEcCtD
Zaleplon—Asthenia—Capecitabine—breast cancer	2.83e-05	0.000115	CcSEcCtD
Zaleplon—Malaise—Doxorubicin—breast cancer	2.81e-05	0.000114	CcSEcCtD
Zaleplon—Dry mouth—Epirubicin—breast cancer	2.8e-05	0.000114	CcSEcCtD
Zaleplon—Vertigo—Doxorubicin—breast cancer	2.8e-05	0.000114	CcSEcCtD
Zaleplon—Anorexia—Methotrexate—breast cancer	2.8e-05	0.000114	CcSEcCtD
Zaleplon—Syncope—Doxorubicin—breast cancer	2.79e-05	0.000114	CcSEcCtD
Zaleplon—Pruritus—Capecitabine—breast cancer	2.79e-05	0.000113	CcSEcCtD
Zaleplon—Confusional state—Epirubicin—breast cancer	2.77e-05	0.000113	CcSEcCtD
Zaleplon—Palpitations—Doxorubicin—breast cancer	2.75e-05	0.000112	CcSEcCtD
Zaleplon—Anaphylactic shock—Epirubicin—breast cancer	2.75e-05	0.000112	CcSEcCtD
Zaleplon—Oedema—Epirubicin—breast cancer	2.75e-05	0.000112	CcSEcCtD
Zaleplon—Hypotension—Methotrexate—breast cancer	2.74e-05	0.000111	CcSEcCtD
Zaleplon—Loss of consciousness—Doxorubicin—breast cancer	2.74e-05	0.000111	CcSEcCtD
Zaleplon—Shock—Epirubicin—breast cancer	2.7e-05	0.00011	CcSEcCtD
Zaleplon—Nervous system disorder—Epirubicin—breast cancer	2.7e-05	0.00011	CcSEcCtD
Zaleplon—Dizziness—Docetaxel—breast cancer	2.7e-05	0.000109	CcSEcCtD
Zaleplon—Hypertension—Doxorubicin—breast cancer	2.69e-05	0.000109	CcSEcCtD
Zaleplon—Tachycardia—Epirubicin—breast cancer	2.68e-05	0.000109	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Methotrexate—breast cancer	2.68e-05	0.000109	CcSEcCtD
Zaleplon—Skin disorder—Epirubicin—breast cancer	2.67e-05	0.000108	CcSEcCtD
Zaleplon—Hyperhidrosis—Epirubicin—breast cancer	2.66e-05	0.000108	CcSEcCtD
Zaleplon—Insomnia—Methotrexate—breast cancer	2.66e-05	0.000108	CcSEcCtD
Zaleplon—Arthralgia—Doxorubicin—breast cancer	2.65e-05	0.000108	CcSEcCtD
Zaleplon—Chest pain—Doxorubicin—breast cancer	2.65e-05	0.000108	CcSEcCtD
Zaleplon—Myalgia—Doxorubicin—breast cancer	2.65e-05	0.000108	CcSEcCtD
Zaleplon—Anxiety—Doxorubicin—breast cancer	2.64e-05	0.000107	CcSEcCtD
Zaleplon—Paraesthesia—Methotrexate—breast cancer	2.64e-05	0.000107	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.64e-05	0.000107	CcSEcCtD
Zaleplon—Discomfort—Doxorubicin—breast cancer	2.62e-05	0.000106	CcSEcCtD
Zaleplon—Anorexia—Epirubicin—breast cancer	2.62e-05	0.000106	CcSEcCtD
Zaleplon—Dyspnoea—Methotrexate—breast cancer	2.62e-05	0.000106	CcSEcCtD
Zaleplon—Somnolence—Methotrexate—breast cancer	2.61e-05	0.000106	CcSEcCtD
Zaleplon—Dizziness—Capecitabine—breast cancer	2.61e-05	0.000106	CcSEcCtD
Zaleplon—Dry mouth—Doxorubicin—breast cancer	2.59e-05	0.000105	CcSEcCtD
Zaleplon—Dyspepsia—Methotrexate—breast cancer	2.59e-05	0.000105	CcSEcCtD
Zaleplon—Rash—Docetaxel—breast cancer	2.57e-05	0.000104	CcSEcCtD
Zaleplon—Hypotension—Epirubicin—breast cancer	2.57e-05	0.000104	CcSEcCtD
Zaleplon—Dermatitis—Docetaxel—breast cancer	2.57e-05	0.000104	CcSEcCtD
Zaleplon—Confusional state—Doxorubicin—breast cancer	2.56e-05	0.000104	CcSEcCtD
Zaleplon—Decreased appetite—Methotrexate—breast cancer	2.55e-05	0.000104	CcSEcCtD
Zaleplon—Headache—Docetaxel—breast cancer	2.55e-05	0.000104	CcSEcCtD
Zaleplon—Anaphylactic shock—Doxorubicin—breast cancer	2.54e-05	0.000103	CcSEcCtD
Zaleplon—Oedema—Doxorubicin—breast cancer	2.54e-05	0.000103	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Methotrexate—breast cancer	2.54e-05	0.000103	CcSEcCtD
Zaleplon—Pain—Methotrexate—breast cancer	2.51e-05	0.000102	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Epirubicin—breast cancer	2.5e-05	0.000102	CcSEcCtD
Zaleplon—Shock—Doxorubicin—breast cancer	2.5e-05	0.000102	CcSEcCtD
Zaleplon—Nervous system disorder—Doxorubicin—breast cancer	2.49e-05	0.000101	CcSEcCtD
Zaleplon—Rash—Capecitabine—breast cancer	2.49e-05	0.000101	CcSEcCtD
Zaleplon—Insomnia—Epirubicin—breast cancer	2.49e-05	0.000101	CcSEcCtD
Zaleplon—Dermatitis—Capecitabine—breast cancer	2.49e-05	0.000101	CcSEcCtD
Zaleplon—Tachycardia—Doxorubicin—breast cancer	2.48e-05	0.000101	CcSEcCtD
Zaleplon—Headache—Capecitabine—breast cancer	2.47e-05	0.0001	CcSEcCtD
Zaleplon—Skin disorder—Doxorubicin—breast cancer	2.47e-05	0.0001	CcSEcCtD
Zaleplon—Paraesthesia—Epirubicin—breast cancer	2.47e-05	0.0001	CcSEcCtD
Zaleplon—Hyperhidrosis—Doxorubicin—breast cancer	2.46e-05	9.99e-05	CcSEcCtD
Zaleplon—Dyspnoea—Epirubicin—breast cancer	2.45e-05	9.96e-05	CcSEcCtD
Zaleplon—Somnolence—Epirubicin—breast cancer	2.44e-05	9.93e-05	CcSEcCtD
Zaleplon—Anorexia—Doxorubicin—breast cancer	2.42e-05	9.85e-05	CcSEcCtD
Zaleplon—Nausea—Docetaxel—breast cancer	2.42e-05	9.83e-05	CcSEcCtD
Zaleplon—Feeling abnormal—Methotrexate—breast cancer	2.42e-05	9.83e-05	CcSEcCtD
Zaleplon—Dyspepsia—Epirubicin—breast cancer	2.42e-05	9.83e-05	CcSEcCtD
Zaleplon—Gastrointestinal pain—Methotrexate—breast cancer	2.4e-05	9.76e-05	CcSEcCtD
Zaleplon—Decreased appetite—Epirubicin—breast cancer	2.39e-05	9.71e-05	CcSEcCtD
Zaleplon—Hypotension—Doxorubicin—breast cancer	2.38e-05	9.65e-05	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Epirubicin—breast cancer	2.37e-05	9.64e-05	CcSEcCtD
Zaleplon—Pain—Epirubicin—breast cancer	2.35e-05	9.55e-05	CcSEcCtD
Zaleplon—Constipation—Epirubicin—breast cancer	2.35e-05	9.55e-05	CcSEcCtD
Zaleplon—Nausea—Capecitabine—breast cancer	2.34e-05	9.52e-05	CcSEcCtD
Zaleplon—Urticaria—Methotrexate—breast cancer	2.33e-05	9.48e-05	CcSEcCtD
Zaleplon—Abdominal pain—Methotrexate—breast cancer	2.32e-05	9.43e-05	CcSEcCtD
Zaleplon—Body temperature increased—Methotrexate—breast cancer	2.32e-05	9.43e-05	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.32e-05	9.41e-05	CcSEcCtD
Zaleplon—Insomnia—Doxorubicin—breast cancer	2.3e-05	9.35e-05	CcSEcCtD
Zaleplon—Paraesthesia—Doxorubicin—breast cancer	2.28e-05	9.28e-05	CcSEcCtD
Zaleplon—Dyspnoea—Doxorubicin—breast cancer	2.27e-05	9.21e-05	CcSEcCtD
Zaleplon—Feeling abnormal—Epirubicin—breast cancer	2.27e-05	9.2e-05	CcSEcCtD
Zaleplon—Somnolence—Doxorubicin—breast cancer	2.26e-05	9.19e-05	CcSEcCtD
Zaleplon—Gastrointestinal pain—Epirubicin—breast cancer	2.25e-05	9.13e-05	CcSEcCtD
Zaleplon—Dyspepsia—Doxorubicin—breast cancer	2.24e-05	9.1e-05	CcSEcCtD
Zaleplon—Decreased appetite—Doxorubicin—breast cancer	2.21e-05	8.98e-05	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Doxorubicin—breast cancer	2.2e-05	8.92e-05	CcSEcCtD
Zaleplon—Urticaria—Epirubicin—breast cancer	2.18e-05	8.87e-05	CcSEcCtD
Zaleplon—Pain—Doxorubicin—breast cancer	2.18e-05	8.84e-05	CcSEcCtD
Zaleplon—Constipation—Doxorubicin—breast cancer	2.18e-05	8.84e-05	CcSEcCtD
Zaleplon—Abdominal pain—Epirubicin—breast cancer	2.17e-05	8.83e-05	CcSEcCtD
Zaleplon—Body temperature increased—Epirubicin—breast cancer	2.17e-05	8.83e-05	CcSEcCtD
Zaleplon—Asthenia—Methotrexate—breast cancer	2.11e-05	8.56e-05	CcSEcCtD
Zaleplon—Feeling abnormal—Doxorubicin—breast cancer	2.1e-05	8.51e-05	CcSEcCtD
Zaleplon—Gastrointestinal pain—Doxorubicin—breast cancer	2.08e-05	8.45e-05	CcSEcCtD
Zaleplon—Pruritus—Methotrexate—breast cancer	2.08e-05	8.44e-05	CcSEcCtD
Zaleplon—Urticaria—Doxorubicin—breast cancer	2.02e-05	8.21e-05	CcSEcCtD
Zaleplon—Abdominal pain—Doxorubicin—breast cancer	2.01e-05	8.17e-05	CcSEcCtD
Zaleplon—Body temperature increased—Doxorubicin—breast cancer	2.01e-05	8.17e-05	CcSEcCtD
Zaleplon—Asthenia—Epirubicin—breast cancer	1.97e-05	8.01e-05	CcSEcCtD
Zaleplon—Pruritus—Epirubicin—breast cancer	1.94e-05	7.9e-05	CcSEcCtD
Zaleplon—Dizziness—Methotrexate—breast cancer	1.94e-05	7.89e-05	CcSEcCtD
Zaleplon—Rash—Methotrexate—breast cancer	1.85e-05	7.52e-05	CcSEcCtD
Zaleplon—Dermatitis—Methotrexate—breast cancer	1.85e-05	7.52e-05	CcSEcCtD
Zaleplon—Headache—Methotrexate—breast cancer	1.84e-05	7.48e-05	CcSEcCtD
Zaleplon—Asthenia—Doxorubicin—breast cancer	1.82e-05	7.41e-05	CcSEcCtD
Zaleplon—Dizziness—Epirubicin—breast cancer	1.82e-05	7.38e-05	CcSEcCtD
Zaleplon—Pruritus—Doxorubicin—breast cancer	1.8e-05	7.31e-05	CcSEcCtD
Zaleplon—Nausea—Methotrexate—breast cancer	1.74e-05	7.09e-05	CcSEcCtD
Zaleplon—Rash—Epirubicin—breast cancer	1.73e-05	7.04e-05	CcSEcCtD
Zaleplon—Dermatitis—Epirubicin—breast cancer	1.73e-05	7.03e-05	CcSEcCtD
Zaleplon—Headache—Epirubicin—breast cancer	1.72e-05	7e-05	CcSEcCtD
Zaleplon—Dizziness—Doxorubicin—breast cancer	1.68e-05	6.83e-05	CcSEcCtD
Zaleplon—Nausea—Epirubicin—breast cancer	1.63e-05	6.63e-05	CcSEcCtD
Zaleplon—Rash—Doxorubicin—breast cancer	1.6e-05	6.51e-05	CcSEcCtD
Zaleplon—Dermatitis—Doxorubicin—breast cancer	1.6e-05	6.51e-05	CcSEcCtD
Zaleplon—Headache—Doxorubicin—breast cancer	1.59e-05	6.47e-05	CcSEcCtD
Zaleplon—Nausea—Doxorubicin—breast cancer	1.51e-05	6.14e-05	CcSEcCtD
Zaleplon—AOX1—Disease—AKT2—breast cancer	1.23e-05	0.000221	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—MED12—breast cancer	1.21e-05	0.000217	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—DPYD—breast cancer	1.21e-05	0.000217	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—ALB—breast cancer	1.2e-05	0.000215	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ALDOA—breast cancer	1.19e-05	0.000214	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—ALB—breast cancer	1.19e-05	0.000213	CbGpPWpGaD
Zaleplon—AOX1—Disease—PIK3CD—breast cancer	1.18e-05	0.000212	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—HRAS—breast cancer	1.18e-05	0.000212	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTA3—breast cancer	1.17e-05	0.000211	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HMMR—breast cancer	1.17e-05	0.000211	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ABCC1—breast cancer	1.17e-05	0.000211	CbGpPWpGaD
Zaleplon—AOX1—Disease—SERPINE1—breast cancer	1.17e-05	0.00021	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—ALB—breast cancer	1.17e-05	0.00021	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NCOA3—breast cancer	1.16e-05	0.000208	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—RAF1—breast cancer	1.15e-05	0.000207	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—SLC2A2—breast cancer	1.15e-05	0.000206	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PPARGC1B—breast cancer	1.14e-05	0.000204	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3CG—breast cancer	1.13e-05	0.000202	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CPT1A—breast cancer	1.13e-05	0.000202	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—MTR—breast cancer	1.13e-05	0.000202	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ABCG2—breast cancer	1.13e-05	0.000202	CbGpPWpGaD
Zaleplon—AOX1—Disease—NOS3—breast cancer	1.12e-05	0.000201	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—HRAS—breast cancer	1.11e-05	0.000199	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—HPGDS—breast cancer	1.1e-05	0.000198	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—HRAS—breast cancer	1.1e-05	0.000198	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—HBA1—breast cancer	1.1e-05	0.000197	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—RAF1—breast cancer	1.08e-05	0.000194	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—HRAS—breast cancer	1.08e-05	0.000194	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—RAF1—breast cancer	1.08e-05	0.000193	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CA9—breast cancer	1.07e-05	0.000193	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTA4—breast cancer	1.07e-05	0.000193	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTT1—breast cancer	1.07e-05	0.000192	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ACHE—breast cancer	1.07e-05	0.000192	CbGpPWpGaD
Zaleplon—AOX1—Disease—MDM2—breast cancer	1.06e-05	0.00019	CbGpPWpGaD
Zaleplon—AOX1—Disease—RAF1—breast cancer	1.06e-05	0.00019	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—RAF1—breast cancer	1.06e-05	0.000189	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTA2—breast cancer	1.05e-05	0.000188	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GPX2—breast cancer	1.05e-05	0.000188	CbGpPWpGaD
Zaleplon—AOX1—Disease—ERBB2—breast cancer	1.05e-05	0.000188	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SULT1A1—breast cancer	1.03e-05	0.000186	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GPX4—breast cancer	1.03e-05	0.000186	CbGpPWpGaD
Zaleplon—AOX1—Disease—MTOR—breast cancer	1.03e-05	0.000185	CbGpPWpGaD
Zaleplon—AOX1—Disease—PIK3CB—breast cancer	1.03e-05	0.000185	CbGpPWpGaD
Zaleplon—AOX1—Disease—CD4—breast cancer	1.03e-05	0.000185	CbGpPWpGaD
Zaleplon—AOX1—Disease—PTGS2—breast cancer	1.02e-05	0.000183	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SYNJ2—breast cancer	1.02e-05	0.000183	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—ALB—breast cancer	1.02e-05	0.000183	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP17A1—breast cancer	1.01e-05	0.000182	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—IDH1—breast cancer	1.01e-05	0.000181	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTA1—breast cancer	1.01e-05	0.000181	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ENO1—breast cancer	1e-05	0.00018	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PTGS1—breast cancer	1e-05	0.00018	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NAT2—breast cancer	9.98e-06	0.000179	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3CD—breast cancer	9.91e-06	0.000178	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP2D6—breast cancer	9.84e-06	0.000177	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ALB—breast cancer	9.79e-06	0.000176	CbGpPWpGaD
Zaleplon—AOX1—Disease—CDKN1B—breast cancer	9.68e-06	0.000174	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NCOA2—breast cancer	9.66e-06	0.000173	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NDUFS3—breast cancer	9.5e-06	0.000171	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—HRAS—breast cancer	9.45e-06	0.00017	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—FASN—breast cancer	9.37e-06	0.000168	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—NOS3—breast cancer	9.36e-06	0.000168	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—BCHE—breast cancer	9.33e-06	0.000167	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—RAF1—breast cancer	9.23e-06	0.000166	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—SLC5A5—breast cancer	9.21e-06	0.000165	CbGpPWpGaD
Zaleplon—AOX1—Disease—CTNNB1—breast cancer	9.15e-06	0.000164	CbGpPWpGaD
Zaleplon—AOX1—Disease—CDKN1A—breast cancer	8.94e-06	0.00016	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CHST9—breast cancer	8.93e-06	0.00016	CbGpPWpGaD
Zaleplon—AOX1—Disease—PTEN—breast cancer	8.92e-06	0.00016	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NQO1—breast cancer	8.9e-06	0.00016	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—SLC2A1—breast cancer	8.9e-06	0.00016	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—MED12—breast cancer	8.75e-06	0.000157	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—DPYD—breast cancer	8.75e-06	0.000157	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP3A4—breast cancer	8.68e-06	0.000156	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3CB—breast cancer	8.64e-06	0.000155	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ALDOA—breast cancer	8.62e-06	0.000155	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PTGS2—breast cancer	8.56e-06	0.000154	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP1B1—breast cancer	8.53e-06	0.000153	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—COX11—breast cancer	8.47e-06	0.000152	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—HSP90AA1—breast cancer	8.37e-06	0.00015	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NCOA3—breast cancer	8.36e-06	0.00015	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SLC2A2—breast cancer	8.31e-06	0.000149	CbGpPWpGaD
Zaleplon—AOX1—Disease—SRC—breast cancer	8.27e-06	0.000148	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NCOA1—breast cancer	8.14e-06	0.000146	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CPT1A—breast cancer	8.14e-06	0.000146	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ABCG2—breast cancer	8.14e-06	0.000146	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—MTR—breast cancer	8.14e-06	0.000146	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—STK11—breast cancer	8.02e-06	0.000144	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP19A1—breast cancer	8.02e-06	0.000144	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HPGDS—breast cancer	7.98e-06	0.000143	CbGpPWpGaD
Zaleplon—AOX1—Disease—STAT3—breast cancer	7.97e-06	0.000143	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HBA1—breast cancer	7.93e-06	0.000142	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CDA—breast cancer	7.75e-06	0.000139	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SHMT1—breast cancer	7.75e-06	0.000139	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ACHE—breast cancer	7.74e-06	0.000139	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTT1—breast cancer	7.74e-06	0.000139	CbGpPWpGaD
Zaleplon—AOX1—Disease—MAPK3—breast cancer	7.62e-06	0.000137	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PTEN—breast cancer	7.47e-06	0.000134	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—COMT—breast cancer	7.46e-06	0.000134	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SLC2A5—breast cancer	7.46e-06	0.000134	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SLCO1B1—breast cancer	7.46e-06	0.000134	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTP1—breast cancer	7.42e-06	0.000133	CbGpPWpGaD
Zaleplon—AOX1—Disease—MYC—breast cancer	7.41e-06	0.000133	CbGpPWpGaD
Zaleplon—AOX1—Disease—TGFB1—breast cancer	7.39e-06	0.000133	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP17A1—breast cancer	7.33e-06	0.000131	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—HMOX1—breast cancer	7.32e-06	0.000131	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ITPR1—breast cancer	7.3e-06	0.000131	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ENO1—breast cancer	7.25e-06	0.00013	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PTGS1—breast cancer	7.25e-06	0.00013	CbGpPWpGaD
Zaleplon—AOX1—Disease—EGFR—breast cancer	7.25e-06	0.00013	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—APRT—breast cancer	7.2e-06	0.000129	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP2D6—breast cancer	7.11e-06	0.000128	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ABCB1—breast cancer	7.03e-06	0.000126	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NCOA2—breast cancer	6.98e-06	0.000125	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—TYMS—breast cancer	6.9e-06	0.000124	CbGpPWpGaD
Zaleplon—AOX1—Disease—KRAS—breast cancer	6.85e-06	0.000123	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTM1—breast cancer	6.82e-06	0.000122	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PLA2G4A—breast cancer	6.82e-06	0.000122	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NCOR1—breast cancer	6.82e-06	0.000122	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ESRRA—breast cancer	6.77e-06	0.000122	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ANGPTL4—breast cancer	6.77e-06	0.000122	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—FASN—breast cancer	6.77e-06	0.000122	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—BCHE—breast cancer	6.74e-06	0.000121	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SLC5A5—breast cancer	6.66e-06	0.00012	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GPX1—breast cancer	6.53e-06	0.000117	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP1A1—breast cancer	6.47e-06	0.000116	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SLC2A1—breast cancer	6.43e-06	0.000115	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NQO1—breast cancer	6.43e-06	0.000115	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HADHB—breast cancer	6.42e-06	0.000115	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GPI—breast cancer	6.42e-06	0.000115	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ERCC2—breast cancer	6.41e-06	0.000115	CbGpPWpGaD
Zaleplon—AOX1—Disease—PIK3CA—breast cancer	6.29e-06	0.000113	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP3A4—breast cancer	6.27e-06	0.000113	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP1B1—breast cancer	6.17e-06	0.000111	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALDH7A1—breast cancer	6.12e-06	0.00011	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALDH1A1—breast cancer	6.12e-06	0.00011	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HSP90AA1—breast cancer	6.05e-06	0.000109	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—MTHFR—breast cancer	6.03e-06	0.000108	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NCOA1—breast cancer	5.88e-06	0.000106	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—UMPS—breast cancer	5.87e-06	0.000105	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ADSL—breast cancer	5.87e-06	0.000105	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PHGDH—breast cancer	5.87e-06	0.000105	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—FHL2—breast cancer	5.87e-06	0.000105	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NME1—breast cancer	5.87e-06	0.000105	CbGpPWpGaD
Zaleplon—AOX1—Disease—HRAS—breast cancer	5.82e-06	0.000104	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—STK11—breast cancer	5.8e-06	0.000104	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP19A1—breast cancer	5.8e-06	0.000104	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—BRIP1—breast cancer	5.76e-06	0.000103	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HPSE—breast cancer	5.76e-06	0.000103	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—LDHB—breast cancer	5.76e-06	0.000103	CbGpPWpGaD
Zaleplon—AOX1—Disease—IL6—breast cancer	5.57e-06	0.0001	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CAV1—breast cancer	5.56e-06	9.98e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTA3—breast cancer	5.46e-06	9.8e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HMMR—breast cancer	5.46e-06	9.8e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ABCC1—breast cancer	5.46e-06	9.8e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—COMT—breast cancer	5.39e-06	9.67e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTP1—breast cancer	5.36e-06	9.63e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HMOX1—breast cancer	5.29e-06	9.5e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PPARGC1B—breast cancer	5.29e-06	9.49e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ITPR1—breast cancer	5.28e-06	9.47e-05	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3CA—breast cancer	5.27e-06	9.45e-05	CbGpPWpGaD
Zaleplon—AOX1—Disease—AKT1—breast cancer	5.14e-06	9.22e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ABCB1—breast cancer	5.08e-06	9.11e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3CG—breast cancer	5.06e-06	9.09e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CA9—breast cancer	4.99e-06	8.96e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTA4—breast cancer	4.99e-06	8.96e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—TYMS—breast cancer	4.99e-06	8.95e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NCOR1—breast cancer	4.93e-06	8.85e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PLA2G4A—breast cancer	4.93e-06	8.85e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTM1—breast cancer	4.93e-06	8.85e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTA2—breast cancer	4.86e-06	8.73e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GPX2—breast cancer	4.86e-06	8.73e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SULT1A1—breast cancer	4.8e-06	8.62e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GPX4—breast cancer	4.8e-06	8.62e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GPX1—breast cancer	4.72e-06	8.47e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—IDH1—breast cancer	4.69e-06	8.42e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTA1—breast cancer	4.69e-06	8.42e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP1A1—breast cancer	4.67e-06	8.39e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NAT2—breast cancer	4.64e-06	8.33e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ERCC2—breast cancer	4.64e-06	8.32e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3CD—breast cancer	4.45e-06	7.99e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ALB—breast cancer	4.39e-06	7.89e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—MTHFR—breast cancer	4.36e-06	7.82e-05	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—AKT1—breast cancer	4.3e-06	7.72e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NOS3—breast cancer	4.2e-06	7.55e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—DPYD—breast cancer	4.07e-06	7.3e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—MED12—breast cancer	4.07e-06	7.3e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CAV1—breast cancer	4.02e-06	7.21e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALDOA—breast cancer	4.01e-06	7.19e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NCOA3—breast cancer	3.89e-06	6.98e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3CB—breast cancer	3.88e-06	6.96e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SLC2A2—breast cancer	3.86e-06	6.93e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PTGS2—breast cancer	3.84e-06	6.9e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CPT1A—breast cancer	3.78e-06	6.79e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ABCG2—breast cancer	3.78e-06	6.79e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—MTR—breast cancer	3.78e-06	6.79e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HPGDS—breast cancer	3.71e-06	6.66e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HBA1—breast cancer	3.69e-06	6.62e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3CG—breast cancer	3.66e-06	6.57e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTT1—breast cancer	3.6e-06	6.46e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ACHE—breast cancer	3.6e-06	6.46e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP17A1—breast cancer	3.41e-06	6.11e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ENO1—breast cancer	3.37e-06	6.05e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PTGS1—breast cancer	3.37e-06	6.05e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PTEN—breast cancer	3.35e-06	6.02e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP2D6—breast cancer	3.31e-06	5.93e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NCOA2—breast cancer	3.25e-06	5.83e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3CD—breast cancer	3.22e-06	5.78e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ALB—breast cancer	3.18e-06	5.7e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—FASN—breast cancer	3.15e-06	5.65e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—BCHE—breast cancer	3.13e-06	5.63e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SLC5A5—breast cancer	3.1e-06	5.56e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NOS3—breast cancer	3.04e-06	5.45e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NQO1—breast cancer	2.99e-06	5.37e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SLC2A1—breast cancer	2.99e-06	5.37e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP1B1—breast cancer	2.87e-06	5.15e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.81e-06	5.05e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3CB—breast cancer	2.8e-06	5.03e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PTGS2—breast cancer	2.78e-06	4.99e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NCOA1—breast cancer	2.73e-06	4.91e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP19A1—breast cancer	2.7e-06	4.84e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—STK11—breast cancer	2.7e-06	4.84e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—COMT—breast cancer	2.51e-06	4.5e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTP1—breast cancer	2.49e-06	4.48e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HMOX1—breast cancer	2.46e-06	4.41e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ITPR1—breast cancer	2.45e-06	4.4e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PTEN—breast cancer	2.42e-06	4.35e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3CA—breast cancer	2.37e-06	4.25e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ABCB1—breast cancer	2.36e-06	4.24e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—TYMS—breast cancer	2.32e-06	4.16e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.29e-06	4.11e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NCOR1—breast cancer	2.29e-06	4.11e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTM1—breast cancer	2.29e-06	4.11e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GPX1—breast cancer	2.19e-06	3.94e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP1A1—breast cancer	2.17e-06	3.9e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ERCC2—breast cancer	2.15e-06	3.87e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—MTHFR—breast cancer	2.03e-06	3.64e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—AKT1—breast cancer	1.93e-06	3.47e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CAV1—breast cancer	1.87e-06	3.35e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3CA—breast cancer	1.71e-06	3.07e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3CG—breast cancer	1.7e-06	3.05e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3CD—breast cancer	1.5e-06	2.69e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALB—breast cancer	1.48e-06	2.65e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NOS3—breast cancer	1.41e-06	2.54e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—AKT1—breast cancer	1.4e-06	2.51e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3CB—breast cancer	1.3e-06	2.34e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PTGS2—breast cancer	1.29e-06	2.32e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PTEN—breast cancer	1.13e-06	2.02e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3CA—breast cancer	7.95e-07	1.43e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—AKT1—breast cancer	6.49e-07	1.17e-05	CbGpPWpGaD
